These facilities are routinely audited to ensure they comply with health, safety, and environmental standards
Understanding your genetic profile helps PlexusDx recommend whether faster-acting satiety (sometimes achieved with consistent morning dosing) or evening-targeted appetite control better matches your biology
Zertifiziert durch Trust Ecommerce Europe und ausgezeichnete Bewertungen auf verschiedenen Plattformen
Ipamorelin shows minimal effect No appetite stimulation: Unlike ghrelin itself, Ipamorelin does not significantly activate hunger pathways in published studies Published Research on Ipamorelin Study Model Key Finding Raun et al., 1998 (Eur J Endocrinol) Swine/Human Selective GH release without cortisol/prolactin elevation Johansen et al., 1999 Human (Phase I/II) Dose-response relationship with no significant adverse effects Bowers et al., 2004 Review Comparative analysis of GHRP selectivity profiles Head-to-Head Comparison Research Factor CJC-1295 Ipamorelin Receptor Target GHRH-R GHS-R1a (Ghrelin receptor) Signaling Pathway cAMP / PKA PLC / Calcium GH Release Pattern Amplifies natural pulsatile release Induces acute GH pulse Cortisol Impact Minimal Minimal Prolactin Impact Minimal Minimal Research Focus Sustained GH elevation models Selective/clean GH pulse models Typical Research Duration No DAC: 30min half-life / DAC: days ~2 hour half-life Why Researchers Study Them Together The combination of a GHRH analog (CJC-1295) with a GHRP (Ipamorelin) is well-documented in published literature
By mapping your genetic profileincluding key variants like GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313PlexusDx can help identify whether your dizziness is tied to how your body processes GLP-1 therapy
